Bionomics Total Assets from 2010 to 2024

BNOX Stock

USD 0.29 0.01 3.57%

Bionomics Total Assets yearly trend continues to be fairly stable with very little volatility. Total Assets are likely to outpace its year average in 2024. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2001-06-30

Previous Quarter

27.6 M

Current Value

22.9 M

Quarterly Volatility

21.9 M

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Bionomics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bionomics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 412.7 K, Interest Expense of 19 K or Other Operating Expenses of 18.8 B, as well as many indicators such as Price To Sales Ratio of 152.7 K, Dividend Yield of 0.0 or PTB Ratio of 0.37. Bionomics financial statements analysis is a perfect complement when working with Bionomics Valuation or Volatility modules.

Check out the analysis of Bionomics Correlation against competitors.

Latest Bionomics' Total Assets Growth Pattern

Below is the plot of the Total Assets of Bionomics Ltd ADR over the last few years. Total assets refers to the total amount of Bionomics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Bionomics ADR books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Bionomics' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bionomics' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 27.65 M

10 Years Trend

Pretty Stable

Compare to Others All Fundamentals

Total Assets

Timeline

Bionomics Total Assets Regression Statistics

	Arithmetic Mean	42,547,713
	Geometric Mean	30,159,764
	Coefficient Of Variation	45.37
	Mean Deviation	15,298,827
	Median	40,689,445
	Standard Deviation	19,302,939
	Sample Variance	372.6T
	Range	68.9M
	R-Value	(0.14)
	Mean Square Error	392.9T
	R-Squared	0.02
	Significance	0.61
	Slope	(622,224)
	Total Sum of Squares	5216.4T

Bionomics Total Assets History

	2024	35.9 M
	2023	27.6 M
	2022	28.6 M
	2021	45.1 M
	2020	40.7 M
	2019	23.8 M
	2018	37.7 M

Other Fundumenentals of Bionomics ADR

Intangibles To Total Assets

Bionomics Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Net Receivables	Intangible Assets	Current Deferred Revenue	Good Will	Short Term Investments	Net Tangible Assets	Long Term Debt	Net Invested Capital	Long Term Investments	Short Long Term Debt	Net Working Capital	Property Plant Equipment	Capital Stock
Total Assets		0.75	-0.47	-0.01	0.63	0.73	0.97	0.4	0.25	0.37	0.87	0.27	0.63	0.84	-0.15	0.43	0.31	0.23	0.25	0.36	0.39	0.12
Total Stockholder Equity	0.75		-0.8	-0.08	0.45	0.1	0.79	-0.19	0.41	0.51	0.63	0.55	0.35	0.49	0.28	0.17	0.5	-0.15	-0.16	0.57	0.06	0.23
Net Debt	-0.47	-0.8		0.18	-0.25	0.12	-0.58	0.38	-0.44	-0.04	-0.23	-0.42	-0.1	-0.2	-0.5	-0.06	-0.48	0.42	0.43	-0.63	0.13	-0.11
Retained Earnings	-0.01	-0.08	0.18		0.0	0.07	0.08	0.16	-0.94	0.16	0.04	0.12	-0.54	-0.25	-0.58	0.75	0.38	0.76	0.72	0.35	0.81	0.43
Accounts Payable	0.63	0.45	-0.25	0.0		0.48	0.57	0.14	0.14	0.22	0.73	0.13	0.22	0.58	-0.33	0.52	-0.08	0.25	0.23	0.11	0.4	-0.18
Total Liab	0.73	0.1	0.12	0.07	0.48		0.65	0.8	-0.05	0.04	0.66	-0.16	0.59	0.76	-0.52	0.47	-0.05	0.51	0.54	-0.05	0.53	-0.06
Total Current Assets	0.97	0.79	-0.58	0.08	0.57	0.65		0.29	0.17	0.39	0.76	0.36	0.51	0.73	-0.12	0.51	0.42	0.21	0.23	0.5	0.44	0.14
Short Term Debt	0.4	-0.19	0.38	0.16	0.14	0.8	0.29		-0.23	-0.17	0.4	-0.33	0.44	0.43	-0.54	0.28	-0.09	0.6	0.64	-0.21	0.47	0.08
Common Stock	0.25	0.41	-0.44	-0.94	0.14	-0.05	0.17	-0.23		0.03	0.17	0.07	0.59	0.37	0.63	-0.63	-0.16	-0.75	-0.72	-0.13	-0.73	-0.3
Net Receivables	0.37	0.51	-0.04	0.16	0.22	0.04	0.39	-0.17	0.03		0.37	0.58	0.22	0.26	-0.03	0.2	0.21	0.11	0.1	0.24	0.18	0.12
Intangible Assets	0.87	0.63	-0.23	0.04	0.73	0.66	0.76	0.4	0.17	0.37		0.18	0.5	0.87	-0.32	0.4	0.11	0.36	0.36	0.11	0.4	0.08
Current Deferred Revenue	0.27	0.55	-0.42	0.12	0.13	-0.16	0.36	-0.33	0.07	0.58	0.18		-0.07	0.03	0.12	0.18	0.21	-0.16	-0.05	0.33	0.14	-0.04
Good Will	0.63	0.35	-0.1	-0.54	0.22	0.59	0.51	0.44	0.59	0.22	0.5	-0.07		0.68	0.2	-0.28	0.0	-0.16	-0.15	-0.05	-0.22	0.07
Short Term Investments	0.84	0.49	-0.2	-0.25	0.58	0.76	0.73	0.43	0.37	0.26	0.87	0.03	0.68		-0.16	0.21	-0.02	0.13	0.15	0.02	0.19	-0.09
Net Tangible Assets	-0.15	0.28	-0.5	-0.58	-0.33	-0.52	-0.12	-0.54	0.63	-0.03	-0.32	0.12	0.2	-0.16		-0.71	0.36	-0.9	-0.88	0.38	-0.78	0.12
Long Term Debt	0.43	0.17	-0.06	0.75	0.52	0.47	0.51	0.28	-0.63	0.2	0.4	0.18	-0.28	0.21	-0.71		0.21	0.74	0.72	0.33	0.92	0.07
Net Invested Capital	0.31	0.5	-0.48	0.38	-0.08	-0.05	0.42	-0.09	-0.16	0.21	0.11	0.21	0.0	-0.02	0.36	0.21		-0.02	0.0	0.92	0.22	0.7
Long Term Investments	0.23	-0.15	0.42	0.76	0.25	0.51	0.21	0.6	-0.75	0.11	0.36	-0.16	-0.16	0.13	-0.9	0.74	-0.02		0.96	-0.09	0.87	0.18
Short Long Term Debt	0.25	-0.16	0.43	0.72	0.23	0.54	0.23	0.64	-0.72	0.1	0.36	-0.05	-0.15	0.15	-0.88	0.72	0.0	0.96		-0.07	0.9	0.14
Net Working Capital	0.36	0.57	-0.63	0.35	0.11	-0.05	0.5	-0.21	-0.13	0.24	0.11	0.33	-0.05	0.02	0.38	0.33	0.92	-0.09	-0.07		0.26	0.55
Property Plant Equipment	0.39	0.06	0.13	0.81	0.4	0.53	0.44	0.47	-0.73	0.18	0.4	0.14	-0.22	0.19	-0.78	0.92	0.22	0.87	0.9	0.26		0.19
Capital Stock	0.12	0.23	-0.11	0.43	-0.18	-0.06	0.14	0.08	-0.3	0.12	0.08	-0.04	0.07	-0.09	0.12	0.07	0.7	0.18	0.14	0.55	0.19

Click cells to compare fundamentals

About Bionomics Financial Statements

Bionomics investors use historical fundamental indicators, such as Bionomics' Total Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Bionomics. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Total Assets	27.6 M	35.9 M
Intangibles To Total Assets	0.51	0.36

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for Bionomics Stock Analysis

When running Bionomics' price analysis, check to measure Bionomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bionomics is operating at the current time. Most of Bionomics' value examination focuses on studying past and present price action to predict the probability of Bionomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bionomics' price. Additionally, you may evaluate how the addition of Bionomics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC